Nathan Price

ISB’s Nathan Price on ‘scientific wellness’ as dominant paradigm of 21st century healthcare

Read the transcript

In this seventh episode, Nathan Price, Professor & Associate Director of the Institute for Systems Biology, explains the concept and aspiration of ‘scientific wellness’. He predicts that it will become the dominant paradigm of 21st century healthcare. He explains ‘personal, dense, dynamic data clouds’ will enable both peak wellness and disease avoidance. Possibilities that China may leapfrog the United States.

Topics we discussed in this episode
  • What is systems biology
  • What are ‘Personal, dense, dynamic data clouds’
  • Quantification of health and wellness
  • Quantification of disease states and transitions into disease states
  • Types of data in a ‘data cloud’
  • ‘Dense phenotyping’
  • Only 10% of a person’s lifetime health can be attributed back to the healthcare system
  • What is ‘scientific wellness’
  • Focusing towards the elements that constitute 90% of a person’s lifetime health
  • 20th century medicine vs 20th century medicine
  • Early triggering and intervention on pre-disease states
  • Societal level issues as cause of disease
  • The Pioneer 100 Study
  • Self empowerment thru knowledge to eliminate for oneself a disease trajectory
  • The 100K Wellness Project
  • The International Human Phenomics Organization
  • China’s deep investment into quantified health and wellness, and early-disease prediction
  • The limitations of the American ‘All of Us Program’
  • Comparison with Verily’s Project Baseline
  • iCarbonX and Human Longevity Incorporated
  • China’s lower regulatory burden than the United States
  • Large food manufactures must pivot towards quantified health and wellness
  • Biological age calculation
  • The human genome has been mis-sold to the public
  • Democratization of wellness centric healthcare
  • ‘Scientific wellness’ will be the dominant paradigm for 21st century medicine
  • Healthcare has misaligned economic and health incentives
  • Competition of innovation in the healthcare marketplace
  • Innovation from outside the current healthcare industry
Show links